Hu Ying, Ge Wenjie, Wang Xingwen, Sutendra Gopinath, Zhao Kunming, Dedeić Zinaida, Slee Elizabeth A, Baer Caroline, Lu Xin
The School of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
Ludwig Institute for Cancer Research Ltd., Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Oncotarget. 2015 Dec 15;6(40):42478-90. doi: 10.18632/oncotarget.6478.
An intriguing biological question relating to cell signaling is how the inflammatory mediator NF-kB and the tumour suppressor protein p53 can be induced by similar triggers, like DNA damage or infection, yet have seemingly opposing or sometimes cooperative biological functions. For example, the NF-κB subunit RelA/p65 has been shown to inhibit apoptosis, whereas p53 induces apoptosis. One potential explanation may be their co-regulation by common cellular factors: inhibitor of Apoptosis Stimulating p53 Protein (iASPP) is one such common regulator of both RelA/p65 and p53. Here we show that iASPP is a novel substrate of caspases in response to apoptotic stimuli. Caspase cleaves the N-terminal region of iASPP at SSLD294 resulting in a prominent 80kDa fragment of iASPP. This caspase cleavage site is conserved in various species from zebrafish to Homo sapiens. The 80kDa fragment of iASPP translocates from the cytoplasm to the nucleus via the RaDAR nuclear import pathway, independent of p53. The 80kDa iASPP fragment can bind and inhibit p53 or RelA/p65 more efficiently than full-length iASPP. Overall, these data reveal a potential novel regulation of p53 and RelA/p65 activities in response to apoptotic stimuli.
一个与细胞信号传导相关的有趣生物学问题是,炎症介质核因子-κB(NF-κB)和肿瘤抑制蛋白p53如何能被类似的触发因素(如DNA损伤或感染)诱导,但却具有看似相反或有时协同的生物学功能。例如,NF-κB亚基RelA/p65已被证明可抑制细胞凋亡,而p53则诱导细胞凋亡。一种可能的解释可能是它们受共同细胞因子的共同调节:凋亡刺激p53蛋白抑制剂(iASPP)就是RelA/p65和p53的这样一种共同调节因子。在此我们表明,iASPP是凋亡刺激下caspase的一种新底物。Caspase在SSLD294处切割iASPP的N端区域,产生一个显著的80kDa的iASPP片段。该caspase切割位点在从斑马鱼到智人的各种物种中都是保守的。iASPP的80kDa片段通过RaDAR核输入途径从细胞质转运到细胞核,与p53无关。80kDa的iASPP片段比全长iASPP能更有效地结合并抑制p53或RelA/p65。总体而言,这些数据揭示了凋亡刺激下p53和RelA/p65活性的一种潜在新调节机制。